Immediate Impact

10 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

Cell death
2024 Standout
Senescent glia link mitochondrial dysfunction and lipid accumulation
2024 StandoutNature
2 intermediate papers

Works of Jianning Yang being referenced

Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies
2015
Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia
2014

Author Peers

Author Last Decade Papers Cites
Jianning Yang 251 75 217 318 233 29 674
Veronica Martini 304 48 148 271 172 40 722
Milena Pantić 221 43 107 358 115 34 700
Frédéric Gilles 200 57 298 372 351 21 745
Althea McCourty 159 78 367 245 302 27 758
Serena Matis 309 51 174 340 208 36 743
Laurent Vallat 229 86 152 260 142 27 610
H Kamesaki 116 23 276 357 235 23 705
Sandra Hermann 96 53 178 305 104 39 734
Kedar Inamdar 151 61 247 386 267 39 752
William H. Towns 213 90 157 322 139 18 682

All Works

Loading papers...

Rankless by CCL
2026